Comerica Bank’s PTC Therapeutics PTCT Stock Holding History
Bought
Maintained
Sold
Other funds holding PTCT
RI
AC
Comerica Bank's PTCT Position: Q4 2025 in Review
Comerica Bank increased its PTC Therapeutics (PTCT) stake by 3,232% in Q4 2025, buying an estimated $1.23M and bringing the position to 17,426 shares worth $1.32M. The position accounts for 0.01% of the portfolio, ranked #1352.
Comerica Bank first reported a position in PTCT in Q3 2023 and has held it in 10 quarters since. 353 funds tracked by Wall St. Rank hold PTCT as of Q4 2025.
- Comerica Bank held 17,426 shares of PTC Therapeutics worth $1.32M as of Q4 2025.
- Comerica Bank bought 16,903 PTC Therapeutics shares in Q4 2025, an estimated $1.23M.
- PTC Therapeutics made up 0.01% of Comerica Bank's portfolio in Q4 2025, its #1352 holding.
- Comerica Bank first reported a position in PTC Therapeutics in Q3 2023 and has held it in 10 quarters since.
- 353 funds tracked by Wall St. Rank held PTC Therapeutics as of Q4 2025.
Based on Comerica Bank's 13F filing for Q4 2025, filed 29 Jan 2026.